The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Atrium Health Foundation has received more than $4 million in grant funding from The Duke Endowment to expand its digital health and education initiatives, including a virtual nursing program, ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

Liver cancer is a malignant tumor characterized by high incidence and mortality rates worldwide. According to the report by the World Health Organization, ...

Adagene Inc. (ADAG) on Tuesday said that it received directions from the U.S. Food and Drug Administration on further ...

A key House committee has blocked a bipartisan amendment to a spending bill that would have given the Department of Defense ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Olivia Enietan, a doctoral student in chemistry and biochemistry, will participate in the prestigious 2025 Clinical and Translational Research Summer Course organized by the National Institutes of ...

VYNE Therapeutics updates on VYN202, addressing FDA clinical hold; progress made in psoriasis treatment development.

A Clinical Trial Application is in development with many parts having been substantially completed. NanoViricides has engaged a Clinical Research Organization (CRO) to organize and conduct this ...

There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate ...